Annual report pursuant to Section 13 and 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
REVENUES:    
Sales $ 1,030,249 $ 267,584
Related party Sales 0 13,069
Total Revenues 1,030,249 280,653
Cost of sales 873,371 159,304
Gross Profit 156,878 121,349
OPERATING EXPENSES:    
Depreciation and amortization 101,334 5,933
Selling and marketing 456,983 420,511
Payroll and related 681,786 411,954
Stock-based compensation 1,207,945 3,014,888
General and administrative 2,419,963 1,122,954
  Total operating expenses 4,868,011 4,976,240
Net loss from operations (4,711,133) (4,854,891)
OTHER INCOME (EXPENSES):    
Interest expense, net (4,302,293) (2,999,291)
Impairment gain (Loss) on Joint Ventures 0 (22,658)
Income (Loss) on equity investment (735,178) 106,305
Gain (loss) on change in fair value of derivative liabilities 3,852 (4,698,072)
Unrealized Gain (loss) on trading securities 504,137 248,204
Realized Gain (loss) on trading securities (543,200) (2,603)
(Loss) Gain on settlement of debt (407,635) 77,624
Total other income (expense) (5,480,317) (7,290,491)
Net loss before income taxes (10,191,450) (12,145,382)
Income taxes (benefit)
NET INCOME (LOSS) (10,191,450) (12,145,382)
Foreign currency Translation Adjustment (11,725)  
Comprehensive Income $ (10,198,883) $ (12,145,382)
Loss per common share, basic and diluted $ (0.00) $ (0.01)
Weighted average number of common shares outstanding, basic and diluted (after stock-split) 5,248,075,532 962,029,388